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MATERIALS AND METHODS
Animals. Mice (C57bl/6j; Charles River Laboratories) were maintained in a temperature-and moisture-controlled environment (20 Ϯ 2°C, 45% humidity) with a 12-h light cycle. Food (Safe) and fresh water were provided ad libitum. Suckling newborn mice were kept with their natural mother until the end of experiments. PPAR␣ null mice (23) In utero glucagon injections. Pregnant mice (17.5 days postcoitum) were anesthetized with isoflurane (4% for induction and then 1%; Minerve). After laparotomy, fetuses from one uterine horn were injected subcutaneously through the uterus wall with 35 g of glucagon (Novo Nordisk), with fetuses in the opposite horn receiving saline as a control. Uterus was then replaced in abdomen, which is stitched. After 2 h, mice were euthanized, fetuses were removed, and their livers were frozen in liquid nitrogen until analysis.
Electromobility shift assay. Mutated COUP-TFII [designated as dominant negative (COUP-TFII-DN)] was designed as described previously (1) by substituting the fourth cysteine in the second zinc finger of COUP-TFII DNA binding domain by a serine (C134 ¡ S) in human COUP-TFII cDNA. For EMSA, nuclear proteins were extracted as described previously (26) . Oligonucleotide containing consensus DR-1 (sense 5=-CGG-CAG-GTC-ACA-GGT-CAT-T-3=, antisense 5=-TGT-AAT-GAC-CTG-TGA-CCT-3=; Eurogentec) were annealed and labeled using [␣Ϫ 32 P]dCTP and Klenow fragment of DNA polymerase I. Unincorporated nucleotides were removed with Sephadex G-50 Nick Columns (GE Healthcare). One nanogram of purified and labeled probe was then incubated at room temperature with 4 ng of nuclear proteins in annealing buffer [10 mmol/l Tris, pH 7.5, 1 mmol/l EDTA, 5% glycerol, and poly(dIdC) 100 nmol/l] for 20 min. Reaction mixture was then run in a 6% native acrylamide gel in 0.25ϫ Tris-Borate-EDTA buffer, heat-and vacuum-dried, and revealed on Kodak Biomax MR films.
Adenoviral vector design and infection GFP and COUP-TFII-DN adenoviral particles were produced by INSERM U649 (Nantes, France). COUP-TFII shRNA sequence was obtained from The RNAi Consortium (access no. TRCN0000026232), and expression was under the control of sp6 promoter. Hairpin sequence was synthesized and cloned, and particles were produced by Genecust (Luxembourg). Four-day-old newborn mice were infected with 6.10 8 plaque-forming units (pfu) of either GFP or COUP-TFII-DN for 24 h or 15.10 9 pfu of GFP or shRNA particles for 96 h. Particles were diluted in PBS in a final injection volume of 20 l and injected in a cheek vein. Blood glucose concentration was measured before and after infection using Accu-Check glucometer (Roche). For WY-14643 experiments (a PPAR␣ agonist), newborn mice were injected subcutaneously after GFP or COUP-TFII-DN adenofection with DMSO or 10 mg/kg WY-14643 diluted in DMSO (Sigma). After decapitation, whole blood was sampled and extracted in ice-cold perchloric acid (6% vol/vol) for metabolic assays or sampled in EDTA-containing vessels for triglyceride measurement. Livers were freeze-clamped in liquid nitrogen for RNA, protein, and metabolite measurements.
Blood and liver metabolite analysis. The frozen livers were weighed, pulverized in a mortar, extracted with 2 vol of perchoric acid (6%), and neutralized. Blood and liver metabolite concentrations were determined in neutralized perchloric filtrates by enzymatic methods, as described previously (15 The gluconeogenic intermediate concentrations in the liver of COUP-TFII-DN or COUP-TFII shRNA-injected newborn mice were expressed as percentage of the concentrations found in GFP control mice. This representation (crossover plot technique) allowed us to localize potential regulatory steps in the gluconeogenic pathway according to the fact that the product of a given enzymatic reaction becomes the substrate for the next one.
Primary cultures of hepatocytes. Six-to eight-week-old fed mice were used. Hepatocytes were isolated as described previously (13) . After cell attachment (4 h), hepatocytes were cultured for 24 h in the absence or in the presence of 100 M dibutyryl-cAMP (Sigma). For WY-14643 experiments, hepatocytes were cultured for 24 h in the absence (DMSO alone) or presence of 10 M WY-14643 diluted in DMSO.
Gene expression. Total RNAs from liver (20 mg) or cells (2.10 6 ) were purified, and mRNA was quantified as described previously (36); see Table 1 for primer sequences. Proteins were extracted and quantified by Western blotting, as described previously (36) .
Lipid extraction and quantification. For hepatic measurement of triacylglycerol and nonesterified fatty acids (NEFA), total lipids were extracted in chloroform-methanol (2:1). Organic phase from 5 mg of liver was applied on silica gel thin-layer chromatography using petroleum ether-diethyl ether-acetic acid (85:15:0.5) as the mobile phase. Once separated, lipid classes (triacylglycerols, diacylglycerols, NEFA, and phospholipids) were colored with iodine vapor and extracted separately in acetone, dried, and directly quantified using NEFA FS and triglyceride FS kits (Diasys), as described previously (4) . Blood triglyceride and NEFA were quantified from EDTA plasma using the same kits.
Statistical analysis. Results are means Ϯ SE. Data were analyzed using a nonparametric Mann-Whitney test.
RESULTS
Developmental changes in hepatic COUP-TFII gene expression. The COUP-TFII mRNA concentration is low in fetal liver and during the immediate postnatal period and then increases to reach maximal levels between 3 and 13 days after birth (Fig. 1A) . It is noteworthy that the peak of COUP-TFII mRNA (day 8) is threefold higher than in the liver of 24-hfasted adult mice (Fig. 1B) . Thereafter, hepatic COUP-TFII mRNA levels decrease in weaned mice to reach values similar to those found in fed adult mice (Fig. 1B) . The postnatal high-fat diet is a source of lipid-derived products that are potent ligands for numerous nuclear receptors, especially PPAR␣ (29) . Interestingly, the developmental pattern of PPAR␣ mRNA parallels those of COUP-TFII (Fig. 1A) . In most mammalian species, birth is characterized by drastic changes in hormonal (fall in insulinemia, rise in glucagonemia) and nutritional environment (fetal high-carbohydrate vs. newborn high-fat diet) (16). Thus we wondered whether a postnatal rise in COUP-TFII mRNA levels could be due to the fall in plasma glucose and insulin concentrations and/or to the rise in plasma free fatty acids and glucagon levels.
Regulation of COUP-TFII gene expression. Intrauterine injections of glucagon were performed in 17.5-day-old fetal mice in which plasma glucagon levels were very low (16) . Glucagon injection induced a 1.7-fold increase in COUP-TFII mRNA levels ( Fig. 2A ) and a threefold increase in PEPCK mRNA level, a well-characterized glucagon target gene. In cultured hepatocytes from adult mice, the effect of glucagon was confirmed by using its second-messenger cAMP, which markedly induced COUP-TFII gene expression (Fig. 2B) . cAMP was used instead of glucagon itself since it is more efficient in 24-h-cultured hepatocytes than glucagon due the higher instability of glucagon and its decreasing concentration in culture media (20, 27) . On the other hand, neither palmitate nor oleate were able to induce COUP-TFII gene expression (Fig. 2C) , whereas it induced carnitine palmitoyltransferase I (CPT I) gene expression, a well-known fatty acid target gene (11) .
The parallel changes in hepatic COUP-TFII and PPAR␣ mRNA during the suckling and weaning periods suggest that these nuclear receptors could be controlled by the same factors and/or mutually regulated. Indeed, the promoter region of COUP-TFII gene contains a DNA motif (DR1) (39) that binds nuclear receptors such as hepatocyte nuclear factor (HNF)-4␣ or PPAR␣. This observation led us to study the contribution of PPAR␣ to COUP-TFII gene expression.
In 24-h-fasted mice, the COUP-TFII mRNA levels are reduced by 45% in the liver of PPAR␣-null mice (Fig. 3A) , whereas expression of acyl-CoA oxidase, a PPAR␣ target gene, is reduced by Ͼ90%. This lower expression of COUP-TFII is maintained in hepatocyte isolated from PPAR␣-null mice (Fig. 3B ). The contribution of PPAR␣ to COUP-TFII gene expression is confirmed in vitro by the effect of WY-14643 (a PPAR␣ agonist), which induces a twofold increase in COUP-TFII mRNA levels in control hepatocytes but not in PPAR␣-null ones (Fig. 3B) .
A recent study has shown that in human hepatoma cells or other cell lines, among the five natural variants of COUP-TFII (34), the one that lacks a DNA-binding domain (COUP-TFII-V2) physically interacts with endogenous COUP-TFII and inhibits its DNA-binding activity (43) , acting as a dominant negative form of COUP-TFII. Whether these mutants are present in mouse liver is unknown, but we took advantage of this observation to investigate the role of a DNA-bindingmutated COUP-TFII in the regulation of hepatic fatty acid and glucose metabolisms.
COUP-TFII-DN characterization and effect on blood and liver metabolites in suckling newborn mice. As shown in Fig. 4A , whereas wild-type (WT)-COUP-TFII recombinant protein binded to a DR1 probe, mutated recombinant COUP-TFII failed to do so. Moreover, increasing mutated COUP-TFII/WT-COUP-TFII molar ratio prevented WT-COUP-TFII binding, and thus the mutated COUP-TFII protein acted as a dominant negative form (COUP-TFII-DN). Twenty-four hours after Ad-COUP-TFII-DN injection, 5-day-old mice presented a profound hypoglycemia, reduced ketone body concentrations, and a rise in triglyceride concentration ( Table 2 ). The twofold increase in blood lactate concentration in COUP-TFII-DN suggested that hypoglycaemia could be due at least in part to a reduced rate of hepatic glucose production. For this purpose, we estimated hepatic gluconeogenic flux by using the crossover plot technique. In COUP-TFII-DN suckling mice, the low hepatic glucose concentration (Fig. 4B) could be due to the 50 -70% reduction in gene expression of PEPCK and glucose-6-phosphatase (G-6-Pase) (Fig. 4C) , which are two regulatory enzymes in gluconeogenesis. Despite reduced PEPCK mRNA levels, the phosphoenolpyruvate concentration was increased in COUP-TFII-DN suckling mouse liver (Fig. 4B) , suggesting that other rate-limiting factors were involved in the reduction of overall gluconeogenesis. Indeed, two reverse crossovers were observed (Fig. 4B) . The first one between pyruvate and oxaloacetate suggests an inhibition of the reaction catalyzed by pyruvate carboxylase. This could result from a decrease in acetyl-CoA concentration (an obligatory cofactor for this enzyme) due to a marked inhibition in hepatic fatty acid oxidation (FAOx), as suggested by the decrease in ketone body production (Fig. 5A ). This inhibition of FAOx resulted from 1) a reduced CPT I and mitochondrial hydroxymethylglutaryl-CoA (mHMG-CoA) synthase gene expression (Fig. 5B) , two regulatory enzymes of FAOx and ketogenic pathways, respectively, and 2) a decrease in liver NEFA concentration (2. The second crossover is located between 3-phosphoglycerate and dihydroxyacetone phosphate (Fig. 4B) 19 ). Because NADH is the cofactor for the reaction catalyzed by glyceraldehyde-3-phosphate dehydrogenase when the flux is oriented toward glucose production, this could explain this second crossover that, associated with reduced G-6-Pase gene expression (Fig. 4C ), leads to a marked fall in gluconeogenic flux.
Effect of PPAR␣ agonist on blood metabolites and liver gene expression in COUP-TFII-DN suckling newborn mice.
It has been shown that COUP-TFII is able to homodimerize and to a lesser extent heterodimerize with retinoid X receptor(RXR) (7, 31) . This could suggest that part of the COUP-TFII-DN effect would be due to the titration of essential transcription factors, such as RXR (the partner of numerous nuclear receptors including COUP-TFII). To approach this question indirectly, we looked at whether it could be possible to rescue FAOx rates in the liver of COUP-TFII-DN mice by activating the expression of CPT I and mHMG-CoA synthase, two PPAR␣ target genes. For this purpose, we used a specific PPAR␣ agonist (WY-14643), assuming that to be fully active, activated PPAR also required dimerization with RXR. As shown in Table 3 , CPT I and mHMG-CoA synthase mRNA return to the control level (GFP) in COUP-TFII-DN/WY-14643-injected mice, whereas neither PEPCK nor G-6-Pase mRNA levels are sta- (Table 3) does not result from direct a effect of WY-16643 on hepatic gluconeogenesis but probably from the rescue in hepatic FAOx rates in response to PPAR␣ agonist.
To further support the specificity of the metabolic effects of COUP-TFII-DN, we investigated the effect of a COUP-TFII shRNA.
Effect of COUP-TFII shRNA on liver gene expression and metabolites in suckling newborn mice. Four days after shRNA injection, the level of COUP-TFII protein was reduced by 60% (Fig. 6A) . COUP-TFII shRNA induced a fall in blood glucose (5.61 Ϯ 0.22 vs. 6.65 Ϯ 0.16 mmol/l for GFP, P Ͻ 0.01; n ϭ 8) and total ketone body (1.23 Ϯ 0.07 vs. 1.72 Ϯ 0.23 mmol/l for Ad-GFP) concentrations. Key gluconeogenic (PEPCK, G-6-Pase) and ketogenic (CPT I, mHMGCoA synthase) gene expression were slightly reduced in COUP-TFII shRNA (in %GFP control: PEPCK, 57 Ϯ 23; G-6-Pase, 88 Ϯ 20; CPT I, 58 Ϯ 22; mHMG-CoA synthase, 60 Ϯ 21). The fact that the effects of sh-COUP-TFII were less pronounced than with COUP-TFII-DN could have resulted from the persistence of a nonnegligible amount of COUP-TFII protein (40% of control GFP; Fig. 6A ) at a developmental stage (7-day-old mice) where COUP-TFII mRNA levels were twofold higher than in COUP-TFII-DN experiments (4 days old; see Fig. 1 ). Despite such a quantitative consideration, COUP-TFII shRNA induced the same two crossovers observed previously with COUP-TFII-DN (between pyruvate and oxaloacetate and between 3-phosphoglycerate and dihydroxyacetone phosphate; Fig. 6B ), suggesting that the reduction in glucose production could result from the decrease in the same regulatory gluconeogenic enzyme activity.
DISCUSSION
The perinatal period is crucial for newborns, especially small rodents such as rat and mice, because of the low amount of carbohydrate in the maternal milk (32) and the scarcity of white fat deposit (21) . The successful adaptation of these neonates to the postnatal changes in nutritional environment requires important modifications of glucose and fatty acid metabolism that are orchestrated mainly by pancreatic hormones (16) and ligand-activated nuclear receptors such as PPAR, LXR, and HNF-4 (29) . The present study provides the first evidence that the orphan nuclear receptor COUP-TFII contributes to the regulation of glucose and fatty acid metabolisms in suckling newborn mice liver. In fetal mouse liver, the low COUP-TFII mRNA levels are probably related to the high plasma insulin concentration that has been shown to exert an inhibitory effect on COUP-TFII gene expression in cultured adult hepatocytes (30) . Indeed, injection of anti-insulin serum in 17.5-day-old mouse fetuses induced a rise in hepatic COUP-TFII mRNA level (data not shown). Conversely, in utero glucagon injection induced hepatic COUP-TFII gene expression. Taken together, these data suggest that the fall in insulin/ glucagon molar ratio that occurs immediately after birth (16) triggers, at least in part, the postnatal increase in hepatic COUP-TFII gene expression. Birth is also characterized by reduced glucose availability and increased lipid-derived substrates. Because glucose exerts an inhibitory effect on COUP-TFII gene expression in adult mice hepatocytes (30) , its low delivery to newborn mice liver could contribute to the postnatal induction of COUP-TFII mRNA levels. By contrast, longchain fatty acids (LCFA) fail to induce COUP-TFII gene expression at least in adult mice hepatocytes, whereas COUP-TFII is controlled by PPAR␣, providing another illustration of the dissociation between PPAR␣ and LCFA in the control of COUP-TFII gene expression (29) .
To get functional relevance of the high level of COUP-TFII gene expression in liver during the suckling period, we devel- oped two different strategies, namely a functional and a genetic invalidation of COUP-TFII protein. Both provide quite similar qualitative results and suggest that COUP-TFII contributes to the preservation of an active hepatic gluconeogenesis and FAOx, with both being crucial for the survival of newborn mice, as illustrated by the drastic (and lethal) hypoglycemia observed in COUP-TFII-DN suckling mice. Because COUP-TFII-DN and shRNA are expressed almost exclusively in hepatocytes, the decrease in blood glucose level in COUP-TFII-DN and to a lesser extent in sh-COUP-TFII newborn mice results from a reduced rate of hepatic gluconeogenesis at both genetic and metabolic levels. The decrease in PEPCK mRNA level in COUP-TFII-DN suckling mice is consistent with the role of this transcription factor in the regulation of PEPCK gene expression (17) . By contrast, the fact that COUP-TFII could be involved in the regulation of G-6-Pase gene expression is yet unknown. Whether this results from a direct effect or from the titration of essential factors by COUP-TFII-DN, such as RXR (the partner of numerous nuclear receptors, including COUP-TFII), remains to be determined. This seems unlikely to explain the overall effects of COUP-TFII-DN since 1) hepatic lipase, a target gene of the farnesoid X receptor/ RXR heterodimer (37) , is unaffected in COUP-TFII-DN mice and 2) activation of the PPAR␣-RXR heterodimer by a specific PPAR␣ agonist partially reverses the metabolic and genetic effects of COUP-TFII-DN (Table 3) .
From a metabolic point of view, the inhibition of hepatic gluconeogenesis is closely related to the reduced rates of hepatic FAOx in COUP-TFII-DN and shRNA-invalidated mice. This inhibition of mitochondrial FAOx, evidenced by the marked fall in hepatic ketone body production, could be due to 1) a decrease in substrate availability and/or 2) a decrease in regulatory gene expression. Indeed, both of these mechanisms seem to be operative. Firstly, if we assume that the sum of FAOx and esterification fluxes represents an estimation of fatty acid uptake, then it is clear that fatty acid uptake is decreased in COUP-TFII-DN mouse liver since esterification (estimated by triglyceride concentration) is unchanged, whereas FAOx is decreased. This is confirmed by the reduced expression of genes encoding regulatory proteins involved in triglyceride hydrolysis (LPL) and fatty acid transporters (CD36 and FABP-1), leading to a decrease in liver NEFA concentration in COUP-TFII-DN mouse liver. Second, inhibition of gene expression encoding regulatory enzyme of LCFA mitochondrial transfer (CPT I) and ketogenesis (mHMG-CoA synthase) markedly impaired FAOx in COUP-TFII-DN newborn mouse liver. Similar results have been found for FABP3 and the muscular isoform of CPT I gene expression in COUP-TFIIinvalidated C 2 C 12 cells (28) . Similarly, COUP-TF (I or II) has been shown to control mHMG-CoA synthase gene expression in adult rat liver (33) . By limiting the provision of essential cofactors, this inhibition of FAOx impacts hepatic gluconeogenesis in both COUP-TFII-DN and sh-COUP-TFII newborn mice. Despite the fact that the regulatory steps have not been determined, similar observations have been made in adult liver of fasting PPAR␣-and PGC-1␣-knockout mice. Invalidation of PPAR␣ depresses mHMG-CoA synthase gene expression (22) , whereas PGC-1␣-knockout decreases the tricarboxylic acid cycle and oxidative phosphorylation gene expression (10) , with both models leading to a reduced rate of FAOx and to hypoglycemia due to impaired hepatic gluconeogenesis. In the present work, the 40% decrease in PGC-1␣ mRNA levels in COUP-TFII-DN mice (even if not statistically different from GFP mice) could be a common partner in the regulation of gluconeogenic and fatty acid oxidation genes by COUP-TFII. Indeed, the contribution of PGC-1␣ in the regulation of these genes expression has been clearly demonstrated (14, 44, 45) .
Crossover plot studies reveal that at least two gluconeogenic steps are affected as a consequence of reduced rates of FAOx. The first crossover is located at the level of pyruvate carboxylation and could result from a decrease in pyruvate availability secondary to the release of pyruvate dehydrogenase (PDH) inhibition by LCFA and/or a reduced pyruvate transport across the mitochondrial membrane. The fact that pyruvate concentration is increased or unchanged in the livers of COUP-TFII-DN and sh-COUP-TFII mice, respectively, probably rules out an effect of LCFA on PDH as being responsible mainly for the inhibition of gluconeogenesis. This suggests that mitochondrial pyruvate uptake in exchange for acetoacetate is probably reduced and then could exert a more pronounced control of pyruvate flux through pyruvate carboxylase. This has been clearly demonstrated in isolated rat hepatocytes (3) and in high-fat diet-induced hepatic gluconeogenesis (8) . Moreover, inhibition of FAOx in COUP-TFII-DN mouse liver reduces acetyl-CoA availability (Fig. 5A) , which could impair pyruvate carboxylase activity, with acetyl-CoA being an obligatory cofactor of this enzyme (2) . The following enzymatic reactions catalyzed by enolase and phosphoglycerate mutase appear to be near equilibrium since the mass action ratios of these two enzymes calculated from the [phophoenolpyruvate]/[2-phosphoglycerate] and [2-phosphoglycerate]/ [3-phosphoglycerate] ratios are unchanged in control (2.39 Ϯ 0.27 and 0.20 Ϯ 0.03 for these 2 ratios, respectively) and COUP-TFII-DN mouse liver (2.09 Ϯ 0.15 and 0.22 Ϯ 0.04 for the 2 ratios, respectively). Therefore, the concentrations of these three metabolites move in the same direction when gluconeogenesis is altered.
The second gluconeogenic step(s) affected by the reduction in FAOx is located at the level of glyceraldehyde-3-phosphate dehydrogenase and/or 3-phosphoglycerate kinase. The scarcity of liver samples in newborn mice does not allow us to determine the concentrations of ATP and ADP, and thus it is difficult to discriminate between these two potential regulatory steps. However, it was shown in newborn rat liver that the variation in the [ATP]/[ADP] ratio was of small magnitude upon a wide range of LCFA oxidation rates (15) . If such is also true in newborn mouse liver, this would suggest that phosphoglycerate kinase does not represent a major step in the regulation of gluconeogenesis by cofactors arising from FAOx. By contrast, in both COUP-TFII-DN and to a lesser extent sh-COUP-TFII mice, the fall in mitochondrial and cytosolic redox states suggests that the activity of glyceraldehyde-3-phosphate dehydrogenase could be limited by the decreased availability in reduced equivalent (NADH) necessary to direct the flux toward glucose production. It is noteworthy that the substrate and product of glyceraldehyde-3-phosphate dehydrogenase (glyceraldehyde-3-phosphate and 1,3-phosphoglycerate, respectively) have not been determined because of their weak concentration in liver. However, as dihydroxyacetone phosphate is near equilibrium with glyceraldehyde-3-phosphate via triose phosphate isomerase, the decrease in dihydroxyacteone phosphate concentration in the liver of both COUP-TFII-DN and sh-COUP-TFII mice reduces gluconeogenesis by decreasing the availability for the subsequent reaction catalyzed by the triose phosphate isomerase. Such a decrease in dihydroxyacteone phosphate concentration has been found in the liver of very-long-chain acyl-CoA dehydrogenase (VLCAD)-invalidated mice (40) . These VLCAD-knockout mice presented a severe hypoglycemia and an impaired hepatic FAOx, but unfortunately, the mechanisms coupling these two parameters had not been determined in this study. Interestingly, when FAOx rates are rescued in response to WY-14643-induced PPAR␣ target genes (CPT I and mHMG-CoA synthase), blood glucose is normalized in COUP-TFII-DN mice.
In conclusion, this work demonstrates that postnatal changes in hormonal (fall in the insulin/glucagon ratio) and nutritional (low glucose delivery to newborn mice) environment are involved in the increase in hepatic COUP-TFII gene expression and that this transcription factor is involved in the regulation of hepatic FAOx, which in turn sustains an active hepatic gluconeogenesis that is essential to maintain an appropriate blood glucose level required for newborn mouse survival. An illustration of the relationships between FAOx and gluconeogenesis as well as the contribution of COUP-TFII and PPAR␣ in the control of genes encoding regulatory steps of these pathways is provided in Fig. 7 .
